President, Chief Executive Officer and Director, BioMarker Strategies
As Principal of Policy Advocates, Inc., from 1995-2001, Mr. Parrott's clients included HGS, Bristol-Myers Squibb, Ciba-Geigy, Diversa, Genentech, HealthCare Ventures, Hoffmann-La Roche, Western Digital and Wyeth. During this period, he helped take public both 3-Dimensional Pharmaceuticals, subsequently acquired by Johnson & Johnson, and InforMax, Inc., subsequently acquired by Invitrogen. He previously held senior policy and corporate communications management positions with Bristol-Myers Squibb Company (1979-1995), American Hospital Supply Corporation (1976-1979), and Walgreen Company (1973-1976).
Mr. Parrott has helped launch important therapeutic products in immunology, oncology, infectious disease and pain relief, and has helped bring two prescription products over the counter. He received his B.A. from the University of South Florida and attended graduate school as a University Fellow at Northwestern University. Mr. Parrott currently serves as Chair of the Board of Directors of Maryland Health Care Product Development Corporation, Senior Advisor to the Maryland Life Sciences Advisory Board, and as a Director of the Tech Council of Maryland and MdBio. He formerly served as Chair of the Biotechnology Industry Organization (BIO) Committee on Outreach and Alliance Development, Chair of the Rx Partners health care reform coalition, Founding Trustee of the Foundation for Genetic Medicine, and Trustee of the Committee for Economic Development.